Garcia Hamilton & Associates’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-3,034
Closed -$523K 48
2017
Q2
$523K Sell
3,034
-4,044
-57% -$658K 0.72% 45
2017
Q1
$1.16M Sell
7,078
-5,684
-45% -$944K 1.02% 35
2016
Q4
$1.87M Buy
12,762
+6,500
+104% +$978K 1.08% 38
2016
Q3
$1.04M Sell
6,262
-411
-6% -$69.5K 0.61% 56
2016
Q2
$1.01M Sell
6,673
-546
-8% -$84.9K 0.61% 59
2016
Q1
$1.08M Sell
7,219
-13
-0.2% -$1.93K 0.63% 59
2015
Q4
$1.17M Buy
7,232
+114
+2% +$17.9K 0.69% 55
2015
Q3
$985K Sell
7,118
-306
-4% -$48.2K 0.6% 56
2015
Q2
$1.14M Sell
7,424
-947
-11% -$152K 0.63% 55
2015
Q1
$1.34M Sell
8,371
-2,433
-23% -$383K 0.65% 57
2014
Q4
$1.72M Sell
10,804
-4,407
-29% -$687K 0.67% 55
2014
Q3
$2.14M Sell
15,211
-3,866
-20% -$505K 0.62% 58
2014
Q2
$2.26M Buy
+19,077
New +$2.21M 0.53% 54

Other funds holding AMGN

Garcia Hamilton & Associates's AMGN Position: Q3 2017 in Review

Garcia Hamilton & Associates sold out of Amgen (AMGN) in Q3 2017, closing a stake of 3,034 shares — an estimated $523K sold.

Garcia Hamilton & Associates first reported a position in AMGN in Q2 2014 and held it in 13 quarters. The position peaked at $2.26M in Q2 2014. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • Garcia Hamilton & Associates reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
  • Garcia Hamilton & Associates sold 3,034 Amgen shares in Q3 2017, an estimated $523K.
  • Garcia Hamilton & Associates first reported a position in Amgen in Q2 2014 and held it in 13 quarters.
  • Garcia Hamilton & Associates's Amgen position peaked at $2.26M in Q2 2014.
  • 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on Garcia Hamilton & Associates's 13F filing for Q3 2017, filed 14 Nov 2017.